Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Childress
NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
A Double Blinded, Placebo-Controlled Pilot Study to Examine Reduction of CD34+/CD117+/CD133+ Lymphoma Progenitor Cells and Duration of Remission Induced by Neoadjuvant Valspodar in Dogs With Large B-Cell Lymphoma
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Related publications
Synthesis and Evaluation of Indenoisoquinoline Topoisomerase I Inhibitors Substituted With Nitrogen Heterocycles
Increased Camptothecin Toxicity Induced in Mammalian Cells ExpressingSaccharomyces cerevisiaeDNA Topoisomerase I
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Clinical Validity of Outcome Pain Measures in Naturally Occurring Canine Osteoarthritis
BMC Veterinary Research
Medicine
Veterinary
Investigation of the StructureActivity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons
Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer
PLoS ONE
Multidisciplinary
Naturally Occurring Mutations to HCV Protease Inhibitors in Treatment-Naïve Patients
Virology Journal
Virology
Infectious Diseases
Liquid Chromatography–tandem Mass Spectrometric Assay for the Quantitation in Human Plasma of the Novel Indenoisoquinoline Topoisomerase I Inhibitors, NSC 743400 and NSC 725776
Journal of Pharmaceutical and Biomedical Analysis
Clinical Biochemistry
Drug Discovery
Analytical Chemistry
Spectroscopy
Pharmaceutical Science
Heterocyclic Bibenzimidazole Derivatives as Topoisomerase I Inhibitors
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Molecular and Cytotoxic Effects of Camptothecin, a Topoisomerase I Inhibitor, on Trypanosomes and Leishmania.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
